-
How to Take the Whole Family Skiing Without Going Broke
Some states and resorts offer discounted passes for children and teens, knowing that those who start young tend to keep coming back.
-
How travel can improve your mental health
We all know that travel can be incredibly good for our physical health – it can help us to de-stress, relax and enjoy some much-needed time away from the hustle and bustle of everyday life. But what about our mental health? Surely spending time away from home, in new and unfamiliar surroundings, can’t be good…
-
7 things to know about protecting your car from thieves
Hundreds of thousands of cars are stolen in the United States each year. Here’s how to keep yours from being among them.
-
Onion Soup With Sour Cream and Potato Chips
This onion soup is inspired by French onion dip with potato chips.
-
Carolyn Hax: Dad resents that ex’s new husband wants to be ‘Daddy’ to his kid
A nasty divorce coupled with hearing his toddler call her stepfather “Daddy” pushes this letter writer to the edge.
-
Ask Amy: Is sex addiction a get-out-of-jail-free card for cheating?
A date has self-diagnosed sex addiction, and this letter writer is too emotionally exhausted to deal with his guilt and drama.
-
Miss Manners: I’m done with my friend who’s always late
Letter writer finally lost it after their friend was late once again.
-
Biosimilar Deals Updates: Biocon, AstraZeneca
As an update to our previous report, Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) announced the successful completion of the transition of the acquired biosimilars business in approximately 120 countries, a year ahead of schedule….By: Goodwin
-
CRISPR Regulatory Updates
On December 15, 2023, Vertex announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the conditional approval of CASGEVY (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited therapy, for the treatment of severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT)….By: Goodwin
-
Updates on Patent Challenges by Biosimilar Manufacturers at the PTAB
In the last month, there has been a flurry of activity at the PTAB related to challenges from biosimilar manufacturers related to ustekinumab, aflibercept, and eculizumab patents….By: Goodwin
